Business NewsPR NewsWire • SIRFLOX Study Presented at ASCO 2015 Annual Meeting

SIRFLOX Study Presented at ASCO 2015 Annual Meeting

SIRFLOX Study Presented at ASCO 2015 Annual Meeting

CHICAGO, May 30, 2015 /PRNewswire/ -- Clinical investigators cite significance of 7.9 month improvement in Progression-Free Survival in the liver for patients with unresectable metastatic colorectal cancer (mCRC) treated first line with SIR-Spheres® Y-90 resin microspheres plus...

View More : http://www.prnewswire.com/news-releases/sirflox-study-presented-at-asco-2015-annual-meeting-505576791.html
Releted News by prnewswire
BOD POD® Body Composition System to be used at the 2015 NHL Scouting Combine
Four NASA Heroes Inducted into U.S. Astronaut Hall of Fame
SIRFLOX Study Presented at ASCO 2015 Annual Meeting
„Belt and Road Initiative" von XCMG startet internationale Servicetour in Xuzhou
David B. Holl Appointed Direct Selling Association Chairman Of The Board